Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study.
Karavasilis V, Samantas E, Koliou GA, Kalogera-Fountzila A, Pentheroudakis G, Varthalitis I, Linardou H, Rallis G, Skondra M, Papadopoulos G, Papatsibas G, Sgouros J, Goudopoulou A, Kalogeras KT, Dervenis C, Pectasides D, Fountzilas G.
Karavasilis V, et al. Among authors: pectasides d.
Target Oncol. 2018 Dec;13(6):715-724. doi: 10.1007/s11523-018-0605-y.
Target Oncol. 2018.
PMID: 30488350
Clinical Trial.